Susan P Stimson insider trades: Intersect ENT (XENT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Susan reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 13, 2019 | XENT | ↓ Sell | 350 | $25.00 | $9K | Direct | Jun 17, 2019 (4d) |
| May 10, 2019 | XENT | ↓ Sell | 5,350 | $27.38 | $146K | Direct | May 14, 2019 (4d) |
| Apr 29, 2019 | XENT | ↓ Sell | 12,500 | $31.06 | $388K | Direct | May 1, 2019 (2d) |
| Apr 23, 2019 | XENT | ↓ Sell | 2,663 | $30.00 | $80K | Direct | Apr 24, 2019 (1d) |
| Apr 10, 2019 | XENT | ↓ Sell | 10,000 | $29.13 | $291K | Direct | Apr 12, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Susan P Stimson's insider trades
Susan P Stimson is Chief Strategy Officer at Intersect ENT (XENT). Since Apr 10, 2019, Susan has reported no open-market purchases and 5 sales worth $915K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (5 filings), grants and awards (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XENT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.